Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DEUTETRABENAZINE
- Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease
- Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated With HD
- A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy
- An Open-label Study to Define the Safety, Tolerability and Clinical Activity of Deutetrabenazine (AUstedo) in Adult Study Subjects With DYsTonia
- Symptomatic Therapy for Patients With Huntington's Disease
- A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
- A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)
- Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents
- Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents
- A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)
- Addressing Involuntary Movements in Tardive Dyskinesia
- Reducing Involuntary Movements in Participants With Tardive Dyskinesia
- Aim to Reduce Movements in Tardive Dyskinesia
- Alternatives for Reducing Chorea in Huntington Disease
- First Time Use of SD-809 in Huntington Disease
Clinical trials list
click for details